Brief: Microba Life Sciences Posts Qtrly Revenue A$3.65M
29/10/2024 01:22
Oct 29 (Reuters) - Microba Life Sciences Ltd MAP.AX :
* QTRLY REVENUE OF A$3.65M
Source text: ID:nASX1VXscZ
Further company coverage: MAP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement